Immunobel-Pro® is a dietary supplement exclusive to healthcare professionals. It is made of our Escherichia coli K-12 RNA Fragments and helps maintain healthy white blood cell and platelet and white blood cell counts.*
Dr. Mirko Beljanski’s researched natural extracts that would help strengthen the immune system. This lead him to create a product to increase the production of platelets and white blood cells—which are both crucial for healthy blood clotting and immunity.*
DNA duplication requires small RNA fragments that function as primers for DNA synthesis. Dr. Beljanski realized that a shortage of these RNA primers in bone marrow stem cells could be primary causes of neutropenia (low white blood cell counts) and thrombocytopenia (low platelet counts). After coming to this conclusion, Dr. Beljanski prepared short fragments of RNA that are specific to bone marrow DNA, and studied their ability at stimulating the proliferation of white blood cells and platelets.12*
Not long ago, a clinical trial at the Cancer Treatment Centers of America showed RNA fragments helped maintain healthy platelet and white blood cell levels in people undergoing chemotherapy (neutropenia and thrombocytopenia are common side effects).3
This is a true scientific breakthrough as it helps patients to finish their treatment uninterrupted and without platelet transfusion or dose reduction.* Immunobel-Pro® contains 40 mg of RNA fragments prepared according to Dr. Beljanski’s exclusive methodology and are available to healthcare professionals for their patients. The RNA fragments are naturally supporting healthy levels of platelet and white blood cell levels without any negative side effects.*
Our formulation does not contain any known allergens. However, while our Manufacturers take steps to minimize the risk of any cross contact, we cannot guarantee that any of our products do not contain trace amounts of, and are safe for consumers with peanut, tree nut, soy, milk, egg, shellfish or wheat allergies.
1 Beljanski M, Plawecki M, Bourgarel P, Beljanski MS. Nouvelles substances (R.L.B.) actives dans la leucopoïèse et la formation des plaquettes. Bull. Acad. Nat. Méd. 1978;(162)6:475-781.
2 Beljanski M. Overview: BLRs as Inducers of In Vivo Leucocyte and Platelet Genesis. Deutsche Zeitschrift für Onkologie. 1992(24)2:41-46.
3 Levin RD, Daehler M, Grutsch Jf, Hall JL, Gupta D, et al. Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia. BMC Cancer. 2010;10:565.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.